NEW podcast episode 🎧 As part of our theme issue on patient and public involvement in rheumatology, Aisling O'Brien talks to Jon Lampa about patient-reported outcomes from the NORD-STAR trial Listen on Apple bit.ly/4rYkOYD Spotify bit.ly/4cdG4oB Full Article bit.ly/411D48I #Medsky #Rheumsky

💥 KABOOM! Our #LupusGPT work is now published in @thelancetrheum.bsky.social‼️ 🏆 A big moment for LupusGPT, but also for what can happen when patient voice is built in from the start, not added at the end. Free. Multilingual. Valid information on lupus doi.org/10.1016/S266...

NEW RESEARCH—Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study bit.ly/4rZwyKH Plus, linked Comment bit.ly/4dgPYHf #Medsky #Rheumsky

Early treatment for #RheumatoidArthritis leads to significant improvements in pain, fatigue, and quality of life – regardless of whether patients receive biologic drugs or conventional therapy. New KI study published in @thelancetrheum.bsky.social 🧪 #Rheumatology news.ki.se/early-initia...

Our April 2026 issue is live! This themed issue on patient and public involvement in rheumatology includes priority setting partnerships, study co-design, and co-production of self-management tools and care pathways, plus much more! thelancet.com/journals/lan... Cover by @emma-cheng.bsky.social

NEW RESEARCH—A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trial bit.ly/4sYp5MO #Medsky #Rheumsky

NEW Correspondence—Effects of abatacept for those at high risk of rheumatoid arthritis @koraytascilar.bsky.social and colleagues report the long-term outcomes of individuals at risk of rheumatoid arthritis treated with abatacept or placebo in the ARIAA trial bit.ly/4lKYGQ3 #Medsky #Rheumsky

NEW RESEARCH—Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis: a multicentre, open-label, Bayesian trial including a randomised reference group to adalimumab bit.ly/4sDik2E Plus, linked Comment bit.ly/3P92Y7B #Medsky #Rheumsky

🍃March issue out now! New data on cardiac events in #COPD, septic shock, climate change and #TB, and much more 🔗 www.thelancet.com/issue/S2213-...

NEW VIEWPOINT—Paediatric rheumatology care in #Europe: setting children and adolescents into focus bit.ly/4cp7usm #Medsky #Rheumsky

Attending the World Congress on #SystemicSclerosis in Athens next week? Anna Clark, Editor-in-Chief, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0

Attending the #EuropeanLupusMeeting in Lisbon next week? Aisling O'Brien, Acting Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0

🆕“The identification of distinct and non-guideline-concordant pathways highlights persistent gaps in primary care management of patients with osteoarthritis. These findings underscore the need for targeted primary care interventions to support... care before knee replacement.” ...

Our March 2026 issue is live! Including research in individuals at risk of developing arthritis, real-world data on anifrolumab in #SLE, #cardiovascular risk in #APS, and childhood-onset Sjögren's disease, plus much more! thelancet.com/journals/lan... #Rheumsky Cover by @emma-cheng.bsky.social

NEW RESEARCH—Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study bit.ly/4bZ4dQe @uspoficial.bsky.social Plus linked Comment bit.ly/3MzdOD4 #Medsky #Rheumsky

NEWS—Frailty care in England deemed deficient bit.ly/4qFV16O #Medsky #Rheumsky

NEW podcast episode🎧 Acting Deputy Editor, Aisling O'Brien, talks to Fiona Pearce & Rachel Tattersall about #HLH mortality rates in Europe Listen now Apple: bit.ly/3Off8LR Spotify: bit.ly/3OFqGYM Full Article: bit.ly/4p5f9hT #Medsky #Rheumsky

🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics! Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0 #medsky

NEW RESEARCH—Patient profiles and early response in patients with systemic #lupus erythematosus initiating #anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study bit.ly/4aj9YWz Plus, linked Comment bit.ly/3ZliHT6 #Medsky #Rheumsky #SLE

Since their introduction 20 years ago, GLP-1 receptor agonists have revolu­tionised the treatment of diabetes and obesity. In our Feb editorial we discuss the current data on GLP-1 receptor agonists in rheumatic disease bit.ly/4c4N5Zi #Medsky #Rheumsky

NEW REVIEW—The path to interception in psoriatic disease: from conceptual clarity to clinical translation bit.ly/3ZD1NPE #Medsky #Rheumsky

Our Feb 2026 issue is live! Including total versus partial knee replacement, vagus nerve stimulation in hand #OA, mortality due to #HLH, #pregnancy outcomes in #vasculitis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky Cover art by @emma-cheng.bsky.social

NEW RESEARCH—Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial bit.ly/4pSERqq Plus, linked Comment bit.ly/49v27Ga #Medsky #Rheumsky

NEW RESEARCH—Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial bit.ly/4pKm4xD #Medsky #Rheumsky

NEW podcast episode🎧 Deputy Editor, Sophie Woolven, talks to John Isaacs & Josh Bennett about #sarcopenia and the RAMUS study, which looked at the skeletal muscle effects tofacitinib in #RA Apple: bit.ly/49fUy6d Spotify: bit.ly/3YSXxeC Full Article: bit.ly/45tQXPn #Medsky #Rheumsky

"the most disastrous year for US public health policy" The US faces a critical public health crossroads as recent policy shifts threaten decades of progress. What are the implications for future health security and scientific integrity? Our Editorial: spkl.io/63326AcVQy

NEW Viewpoint—Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits bit.ly/4apjdGd #Medsky #Rheumsky

NEW RESEARCH—Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study bit.ly/4p5f9hT #HLH @racheltattersall.bsky.social

EBV and #SLE: causal or concurrence? Read our Jan 2026 editorial bit.ly/49hm6I4 #Medsky #Rheumsky

Our Jan 2026 issue is live! Including #RheumatoidArthritis, #IgG4-related disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky And introducing our cover artist for 2026, Emma Cheng @emma-cheng.bsky.social

NEW REVIEW—Skin cancer in inflammatory arthritis: should we advise screening? bit.ly/3MsvsIc #Medsky #Rheumsky

NEW RESEARCH—Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study bit.ly/4rCIa77 #Medsky #Rheumsky

NEW RESEARCH—Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial bit.ly/4pAMZMq #Medsky #Rheumsky #Orthosky

Our December issue is live! Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social Free to read with registration on lancet.com

NEW COMMENT—Revisiting safety and refining benefit of rituximab–belimumab combination for refractory #SLE bit.ly/4hWxegq #Medsky #Rheumsky

NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm Plus, linked Comment bit.ly/4hOOOmz #Medsky #Rheumsky

Our December issue is out now at www.thelancet.com/journals/lan... Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more! #GastroSky #LiverSky #MedSky

👉 Register now: hubs.li/Q03NdTNP0 📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration. #neurology #brainhealth #lancetwebinar

NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN Plus, linked Comment bit.ly/4oJVcgV #Medsky #Rheumsky

🔥Hot off the press for #ACR25 🔥 Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm Plus, linked Comment bit.ly/4300NHF #Medsky #Rheumsky

NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social

Severe #glucocorticoid-induced #osteoporosis requires a long-term sequential treatment approach consisting of a bone anabolic agent followed by an antiresorptive drug www.thelancet.com/journals/lan... #OpenAccess #MedSky #EndoSky #RheumSky

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky

NEW—The Nobel celebrates tolerance News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social

NEW Profile—Sharon Dowell: specialised treatment for the many bit.ly/4owCwkL #Medsky #Rheumsky

Our November issue is live! Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0

Want to stay up to date with the latest original research, perspectives and insights in your field? 🏥 Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group. 🔗 thelancet.com/collections

ICYMI